Pathophysiology of lipid droplet proteins in liver diseases.
Carr RM, Ahima RS. 2016
Insulin resistance in clinical and experimental alcoholic liver disease. Carr RM, Correnti J. 2015
FXR agonists as therapeutic agents for non-alcoholic fatty liver disease. Carr RM, Reid AE. 2015
Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice.
Carr RM, Peralta G, Yin X, Ahima RS. 2014
Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice.
Carr RM, Dhir R, Yin X, Agarwal B, Ahima RS.2013
Understanding the pathogenesis of insulin resistance in non-alcoholic and alcoholic liver diseases.
Carr RM. 2013
Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice.
Carr RM, Patel RT, Rao V, Dhir R, Graham MJ, Crooke RM, Ahima RS. 2012
Alas! Ileal interposition surgery for diabetes prevention? Ahima RS, Carr RM. 2010
At the crossroads in the management of gastroesophageal junction carcinomas-where do we go from here?
Carr RM, Lynch JP. 2008
Perilipin staining distinguishes between steatosis and non-alcoholic steatohepatitis in adults and children
Carr RM, Dhir R,Mahadev K, Comerford M, Chalasani NP, Ahima RS. 2016